|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/14 | |
| C07D 401/14 | |||
| A61K 31/4178 | |||
| A61K 31/4025 | |||
| A61P 31/12 | |||
| C07D 405/14 |
| (11) | Patento numeris | 2880030 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13824843.0 |
| Europos patento paraiškos padavimo data | 2013-08-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2013/000915 |
| Data | 2013-08-05 |
| (87) | Numeris | WO 2014/019344 |
| Data | 2014-02-06 |
| (30) | Numeris | Data | Šalis |
| 201210273491 | 2012-08-03 | CN | |
| 201310116933 | 2013-04-03 | CN |
| (72) |
ZHANG, Yingjun, CN
ZHANG, Jiancun, CN
XIE, Hongming, CN
REN, Qingyun, CN
TAN, Yumei, CN
LUO, Huichao, CN
|
| (73) |
Sunshine Lake Pharma Co., Ltd.,
No. 1, Gongye North Road Northern Industrial Area Songshan Lake, Dongguan, Guangdong 523000,
CN
|
| (54) | BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF |
| BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF |